12th Five-Year Plan For Pharmaceutical Sector To Boost Domestic Industry

BMI View: Major domestic pharmaceutical companies will benefit from China's 12th five-year plan (FYP) for the pharmaceutical industry, as the government aims to improve the whole industry through consolidation and enhance efficiency. Local companies with a focus on research and development (R&D), existing partnerships with foreign firms, modern facilities and that are looking abroad will outperform.

To read the full article, please choose one of the following options: